Table 1.

Number of case and control subjects, adjusted odds ratios, and 95% confidence intervals by diagnosis for the NQO1 enzyme, using wild type as the reference

Diagnosis*Wild typeHeterozygote + Homozygote
CaseControlCaseControlOR95% CI
Acute leukemia 285 562 205 274 1.49 (1.17, 1.89)  
AML 244 484 175 235 1.47 (1.13, 1.90) 
 AML M0 14 27 10 1.39 (0.41, 4.71)  
 AML M1 47 86 28 42 1.33 (0.67, 2.63)  
 AML M2 49 110 47 53 2.01 (1.17, 3.45)  
 AML M3 34 59 19 31 1.22 (0.58, 2.53)  
 AML M4 40 77 31 43 1.29 (0.70, 2.36)  
 AML M5 23 51 14 13 2.59 (1.00, 6.71)  
 AML M6 12 24 1.42 (0.34, 5.93)  
 AML M7 0.29 (0.01, 6.50) 
ALL 36 73 29 35 1.93 (0.96, 3.87)  
 ALL B 22 50 24 28 2.20 (0.99, 4.89)  
 ALL T 13 1.50 (0.19, 11.94) 
Diagnosis*Wild typeHeterozygote + Homozygote
CaseControlCaseControlOR95% CI
Acute leukemia 285 562 205 274 1.49 (1.17, 1.89)  
AML 244 484 175 235 1.47 (1.13, 1.90) 
 AML M0 14 27 10 1.39 (0.41, 4.71)  
 AML M1 47 86 28 42 1.33 (0.67, 2.63)  
 AML M2 49 110 47 53 2.01 (1.17, 3.45)  
 AML M3 34 59 19 31 1.22 (0.58, 2.53)  
 AML M4 40 77 31 43 1.29 (0.70, 2.36)  
 AML M5 23 51 14 13 2.59 (1.00, 6.71)  
 AML M6 12 24 1.42 (0.34, 5.93)  
 AML M7 0.29 (0.01, 6.50) 
ALL 36 73 29 35 1.93 (0.96, 3.87)  
 ALL B 22 50 24 28 2.20 (0.99, 4.89)  
 ALL T 13 1.50 (0.19, 11.94) 

NQO1 indicates NAD(P)H:quinone oxidoreductase 1; OR, odds ratio; CI, confidence interval; AML, acute myeloid leukemia; and ALL, acute lymphoblastic leukemia.

*

Four cases had a diagnosis of acute biphenotypic leukemia, and 2 cases had a diagnosis of unspecified acute leukemia.

Wild type showed high activity of NQO1 enzyme; heterozygote, low activity; and homozygote, no activity. Samples for 3 cases and 2 controls would not amplify.

Odds ratios were estimated by means of conditional logistic regression adjusted for deprivation.

or Create an Account

Close Modal
Close Modal